Geron Stock Analysis

Geron Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.32. Geron had not issued any dividends in recent years. The entity had 1058:1000 split on the 22nd of July 2014. Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people. To learn more about Geron call the company at 650 473 7700 or check out https://www.geron.com.

Geron Investment Alerts

Geron Upcoming and Recent Events

Geron Largest EPS Surprises

View All Earnings Estimates

Geron Environmental, Social, and Governance (ESG) Scores

Geron Thematic Classifications

Geron Stock Institutional Investors

Note, although Geron's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Geron Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.52 B.

Geron Profitablity

Management Efficiency

Geron has return on total asset (ROA) of (0.303) % which means that it has lost $0.303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6903) %, meaning that it created substantial loss on money invested by shareholders. Geron's management efficiency ratios could be used to measure how well Geron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.49. In addition to that, Return On Capital Employed is likely to drop to -0.71. At this time, Geron's Total Assets are very stable compared to the past year. As of the 2nd of December 2024, Non Current Assets Total is likely to grow to about 55.4 M, while Non Currrent Assets Other are likely to drop about 4.5 M.

Technical Drivers

As of the 2nd of December, Geron retains the Risk Adjusted Performance of (0.02), market risk adjusted performance of (0.09), and Standard Deviation of 2.9. Geron technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Geron Price Movement Analysis

Geron Insider Trading Activities

Geron Outstanding Bonds

Geron Predictive Daily Indicators

Geron Corporate Filings

Geron Forecast Models

Geron's time-series forecasting models are one of many Geron's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Geron's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Geron prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Geron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Geron. By using and applying Geron Stock analysis, traders can create a robust methodology for identifying Geron entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Geron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Geron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Geron stock analysis indicators help investors evaluate how Geron stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Geron shares will generate the highest return on investment. By understating and applying Geron stock analysis, traders can identify Geron position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.